Published in Life Sci on March 15, 1977
Prostaglandin E inhibits the production of human interleukin 2. J Exp Med (1982) 2.34
Antihemostatic, antiinflammatory, and immunosuppressive properties of the saliva of a tick, Ixodes dammini. J Exp Med (1985) 1.97
Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J Exp Med (1979) 1.51
Alveolar response to experimental Pneumocystis carinii pneumonia in the rat. Am J Pathol (1980) 1.46
Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J (1978) 1.33
The use of concanavalin A to study the immunoregulation of human T cells. Clin Exp Immunol (1981) 1.15
Prostaglandin E modulation of the mitogenic response of human T cells. Differential response of T-cell subpopulations. J Clin Invest (1979) 1.10
Lymphocyte traffic through antigen-stimulated lymph nodes. II. Role of Prostaglandin E2 as a mediator of cell shutdown. Immunology (1981) 1.09
Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy. J Clin Invest (1981) 1.04
The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors. Clin Exp Immunol (1979) 0.95
Regulation of human immunoglobulin production in vitro by prostaglandin E2. Clin Exp Immunol (1982) 0.92
The distribution of prostaglandins in afferent and efferent lymph from inflammatory sites. Am J Pathol (1980) 0.90
Regulation of human B cell activation by prostaglandin E2. Suppression of the generation of immunoglobulin-secreting cells. J Clin Invest (1985) 0.86
Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs. Br J Cancer (1980) 0.85
Dietary fatty acid effects on T-cell-mediated immunity in mice infected with mycoplasma pulmonis or given carcinogens by injection. Am J Pathol (1987) 0.82
Linoleic acid therapy in severe experimental allergic encephalomyelitis in the guinea-pig: suppression by continuous treatment. Clin Exp Immunol (1980) 0.79
Effect of prostaglandins and cyclic adenosine 3',5'-monophosphate modulators on herpes simplex virus growth and interferon response in human cells. Infect Immun (1980) 0.78
Macrophages as targets of inhibitory effects of E-type prostaglandins in immune-related inflammation. Agents Actions (1981) 0.77
Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS. Neurol Neuroimmunol Neuroinflamm (2016) 0.75
A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. Science (1998) 1.86
Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation. Proc Natl Acad Sci U S A (1979) 1.63
CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol (1998) 1.60
Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J Exp Med (1979) 1.51
Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood (1998) 1.42
Prostaglandin synthesis inhibition: effect on bone changes and sarcoma tumor induction in balb/c mice. Int J Cancer (1975) 1.33
Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells. J Immunol (1988) 1.11
Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking. Leukemia (2010) 1.09
Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors. Ann N Y Acad Sci (1999) 1.08
CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors. Cell Immunol (1999) 1.04
Association between colony forming units-granulocyte macrophage expression of Ia-like (HLA-DR) antigen and control of granulocyte and macrophage production. A new role for prostaglandin E. J Clin Invest (1982) 1.04
Monocyte-conditioned medium and interleukin 1 induce granulocyte-macrophage colony-stimulating factor production in the adherent cell layer of murine bone marrow cultures. Exp Hematol (1986) 0.99
Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E. Exp Hematol (1984) 0.98
Immune system modulation and its effect on the blood pressure of the spontaneously hypertensive male and female rat. Biochem Biophys Res Commun (1981) 0.98
Regulation of human myelopoiesis by prostaglandin E and lactoferrin. Cell Tissue Kinet (1981) 0.98
In vivo modulation of murine myelopoiesis following intravenous administration of prostaglandin E2. Blood (1983) 0.98
Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice. Int J Cancer (1976) 0.97
Prostaglandins and cyclic nucleotides in Moloney sarcoma tumors. Prostaglandins (1974) 0.95
Increased prostaglandin synthesis by macrophages from tumor-bearing mice. J Immunol (1979) 0.94
Macrophage-inflammatory protein-3 beta/EBI1-ligand chemokine/CK beta-11, a CC chemokine, is a chemoattractant with a specificity for macrophage progenitors among myeloid progenitor cells. J Immunol (1998) 0.90
Expansion of bone marrow neutrophils following G-CSF administration in mice results in osteolineage cell apoptosis and mobilization of hematopoietic stem and progenitor cells. Leukemia (2012) 0.90
Quantitative differences in immune responses during the various stages of the estrous cycle in female BALB/c mice. J Immunol (1978) 0.88
Isolation and preservation of human myoglobin for use in immunologic detection of myoglobinuria. Proc Soc Exp Biol Med (1966) 0.88
Effects of sex hormones on some T and B cell functions, evidenced by differential immune expression between male and female mice and cyclic pattern of immune responsiveness during the estrous cycle in female mice. Am J Reprod Immunol (1981) 0.87
Prostaglandin E acts at two levels to enhance colony formation in vitro by erythroid (BFU-E) progenitor cells. Exp Hematol (1987) 0.87
Multiple lymphokine production by a phorbol ester-stimulated mouse thymoma: relationship to cell cycle events. J Natl Cancer Inst (1983) 0.86
In vivo modulation of myelopoiesis by prostaglandin E2. IV. Prostaglandin E2 induction of myelopoietic inhibitory activity. J Immunol (1988) 0.85
Detergent enhancement of insulin-induced hypoglycemia in rats. Proc Soc Exp Biol Med (1968) 0.85
The role of marrow accessory cell populations in the augmentation of human erythroid progenitor cell (BFU-E) proliferation by prostaglandin E. Leuk Res (1989) 0.85
In vivo modulation of myelopoiesis by prostaglandin E2. II. Inhibition of granulocyte-monocyte progenitor cell (CFU-GM) cell-cycle rate. Exp Hematol (1987) 0.84
Cell cycle specific effects of deferoxamine on human and murine hematopoietic progenitor cells. Cancer Res (1988) 0.83
Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1. Cancer Res (1980) 0.82
Immune responses of rats chronically fed subclinical doses of lead. Clin Exp Immunol (1981) 0.82
Sex-related immunocompetence of BALB/c mice. I. Study of immunologic responsiveness of neonatal, weanling, and young adult mice. J Immunol (1979) 0.82
Detection of luxol-fast-blue positive cells in human promyelocytic leukemia cell line HL-60. Exp Hematol (1981) 0.81
Characterization of H-2Db antigens implies haplotype differences in the number of H-2 molecules expressed. J Immunol (1982) 0.80
Growth inhibitory effect of Hcc-1/CIP29 is associated with induction of apoptosis, not just with G2/M arrest. Cell Mol Life Sci (2005) 0.80
Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation. Stem Cells (2000) 0.79
Arteriosclerosis: is stress-induced immune suppression a risk factor? Science (1977) 0.79
Identification of unique truncated KC/GRO beta chemokines with potent hematopoietic and anti-infective activities. J Immunol (2000) 0.79
Physiological consequences of beta-adrenoceptor desensitization in guinea pigs. Eur J Pharmacol (1983) 0.78
Macrophage-induced T cell mitogen suppression with age. J Reticuloendothel Soc (1980) 0.78
SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells. Blood Cells Mol Dis (2000) 0.78
Specific inhibitory activity against granulocyte-progenitor cells produced by non-T lymphocytes from patients with neutropenia. Exp Hematol (1980) 0.78
Lymphokines secreted from sodium periodate-treated lymphocytes. Cell Immunol (1980) 0.77
Isolation of viable rat kidney tubules. Life Sci II (1971) 0.77
Abnormal colony formation and prostaglandin E responsiveness of myeloid progenitor cells in patients cured of germ cell neoplasms after combination chemotherapy. Cancer (1987) 0.77
Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis. J Clin Oncol (1983) 0.77
Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells. Leukemia (1988) 0.77
Effects of indomethacin on Moloney sarcoma virus-induced tumors. Prostaglandins (1974) 0.77
Prostaglandin-E-mediated modulation of human marrow CFU-GM Ia-antigen expression: kinetics and specificity. Exp Hematol (1984) 0.77
Inhibition of tumor growth and survival of aged mice inoculated with Moloney tumor transplants and treated with endotoxin. Cancer Res (1972) 0.76
Effects of sex hormones on some T and B cell functions as evidenced by differential immune expression between male and female mice and cyclic pattern of immune responsiveness during the estrous cycle. Prog Clin Biol Res (1981) 0.76
Evaluation of T cell subpopulation and function in thymosin treated spontaneously hypertensive rats. Thymus (1984) 0.76
Phenotypic evaluation of chronic myeloid leukemia. Blood Cells (1981) 0.76
Hematopoietic and hematologic properties of bestatin in normal and cyclophosphamide myelosuppressed mice. Biomed Pharmacother (1990) 0.75
Production of and responsiveness to interleukin 2 in autoimmune BXSB mice. Cell Immunol (1987) 0.75
Sex-related immunocompetence of BALB/C mice. II. Study of immunologic responsiveness of young, adult and aged mice. Dev Comp Immunol (1981) 0.75
Structure-activity relationships of novel hematoregulatory peptides. J Med Chem (1996) 0.75
Increase in the severity of allergic-type bronchospasm in sensitized and challenged cats treated with cortisone. Int Arch Allergy Appl Immunol (1977) 0.75
The effect of insulin and sodium dodecyl sulfate on rat hepatic cell respiration. Arch Biochem Biophys (1969) 0.75
Hematopoietic and therapeutic properties of bestatin in normal and myelosuppressed mice. Biomed Pharmacother (1991) 0.75
Altered immune reactivity in encephalomyocarditis-M variant (EMC-M)-induced diabetes in mice. Immunol Commun (1979) 0.75
Immune-complex induced prostaglandin production by monocytes of normal human subjects and cancer patients. Prostaglandins Med (1980) 0.75
Increase in serum IgE levels of ovalbumin-sensitized cats and the detection of elastase and collagenase activities in secretions of sensitized feline alveolar macrophages challenged in vitro. Int Arch Allergy Appl Immunol (1977) 0.75
Quantitation of human tumor antigens by immunodiffusion tests. Trans N Y Acad Sci (1965) 0.75
Complete remission in pure red cell aplasia after plasmapheresis. Scand J Haematol (1985) 0.75
Immune response modulation in the spontaneously hypertensive rat. Thymus (1983) 0.75
Immunosuppression as a homeostatic mechanism in disease and aging. Adv Exp Med Biol (1979) 0.75
Novel peptidomimetic hematoregulatory compounds. Bioorg Med Chem Lett (2000) 0.75
The effect of neonatal thymectomy in the induction of experimental autoimmune thyroiditis in the rat. Experientia (1972) 0.75
Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide, HP-5. Exp Hematol (1992) 0.75
Stimulation of the hemagglutinin response of aged mice by cell-free lymphoid tissue fractions and bacterial endotoxin. Exp Gerontol (1971) 0.75
Altered immune complex-induced prostaglandin production in human and murine lupus. Prostaglandins Med (1981) 0.75
Hematoregulators. A case history of a novel hematoregulatory peptide, SK&F 107647. Pharm Biotechnol (1998) 0.75
Alterations to maternal cortical and trabecular bone in multiparous middle-aged mice. J Musculoskelet Neuronal Interact (2017) 0.75